Leishmaniasis, caused by a protozoan parasite, is among humanity's costliest banes, owing
to the high mortality and morbidity ratio in poverty-stricken areas. To date, no vaccine is …

Leishmaniasis, which is caused by a parasitic protozoan of the genus Leishmania, is still a
major threat to global health, impacting millions of individuals worldwide in endemic areas …

Leishmaniasis, one of the neglected diseases, ranks second to malaria in the cause of
parasitic mortality and morbidity. The present chemotherapeutic regimen faces the …

The main challenges associated with leishmaniasis chemotherapy are drug toxicity, the
possible emergence of resistant parasites, and a limited choice of therapeutic agents …

Leishmaniasis is a disease caused by the parasite Leishmania donovani affecting
populations belonging to developing countries. The present study explores drug …

Leishmaniasis is a group of protozoan parasitic diseases caused by various Leishmania
species. The clinical manifestations range from skin abrasions to lethal infection in the …

In this study, anti-leishmanial activities were performed on silver oxide nanoparticles green
synthesized from hexane, ethereal, chloroform, and methanolic extracts of the Ericaria …

Leishmaniasis is an infectious disease caused by protozoan species in the genera
Leishmania and Endotrypanum. Current antileishmanial drugs are limited due to adverse …

Parthenium hysterophorus plant has a diverse chemical profile and immense bioactive
potential. It exhibits excellent pharmacological properties such as anti-cancer, anti …

Leishmaniasis is a neglected tropical disease that has affected more than 350 million
people worldwide and can manifest itself in three different forms: cutaneous …